Valuation: Alfresa Holdings Corporation

Market Cap 408B 2.63B 2.28B 2.16B 1.95B 3.66B 252B 3.69B 25.72B 9.9B 128B 9.88B 9.67B P/E 2027 *
17.8x
P/E 2028 * 14.7x
Enterprise Value 408B 2.63B 2.28B 2.16B 1.95B 3.66B 252B 3.69B 25.72B 9.9B 128B 9.88B 9.67B EV / Sales 2027 *
0.13x
EV / Sales 2028 * 0.12x
Free-Float
88.35%
Yield 2027 *
3.05%
Yield 2028 * 3.39%
06-30 Ember LifeSciences, Inc. announced that it has received funding from Alfresa Holdings Corporation CI
06-21 Alfresa Holdings Corporation(TSE:2784) dropped from S&P Japan Mid Cap 100 CI
05-26 ReeNT Co., Ltd. announced that it expects to receive ¥600 million in funding from Alfresa Holdings Corporation CI
05-26 Alfresa Holdings Corporation concluded a share transfer agreement to acquire Nagashima Medical Instruments Co., Ltd. from Nagashima Holdings Co., Ltd. CI
05-18 Alfresa Holdings Corporation's Equity Buyback announced on May 15, 2026, has closed with 6,307,800 shares, representing 3.47% for ¥14,999.95 million. CI
05-18 Tranche Update on Alfresa Holdings Corporation's Equity Buyback Plan announced on May 15, 2026. CI
05-15 Alfresa Holdings Corporation authorizes a Buyback Plan. CI
05-15 Alfresa Holdings Corporation announces an Equity Buyback for 6,307,800 shares, representing 3.46% for ¥14,999.95 million. CI
05-15 Alfresa Holdings Corp - to buy back up to 3.5% of own shares worth about 15 billion yen RE
05-15 Alfresa Holdings Corporation Announces Cash Dividend for the Year-End of the Fiscal Year Ended March 31, 2026, Payable on June 2, 2026; Provides Cash Dividend Guidance for the Second Quarter-End and Year-End of the Fiscal Year Ending March 31, 2027 CI
05-15 Alfresa Holdings Corporation Provides Consolidated Earnings Guidance for the Six Months Ending September 30, 2026 and for the Fiscal Year Ending March 31, 2027 CI
04-07 Healios Secures 144 Million Yen Initial Order from Alfresa's Korean Unit for Cosmetic Raw Material MT
02-26 Alfresa Holdings Corporation concluded a share transfer agreement to acquire Techno Suzuta, Co.,Ltd. from Onsendo, K.K. CI
1 day-1.81%
3 months-1.81%
6 months-17.30%
Current year-10.50%
Current year 13
Extreme 13
16.81
1 year 11.39
Extreme 11.39
16.81
3 years 11.39
Extreme 11.39
16.81
5 years 11.39
Extreme 11.39
16.81
10 years 11.39
Extreme 11.39
23.35
Manager TitleAgeSince
Chief Executive Officer 63 -
Chief Administrative Officer - -
Chief Tech/Sci/R&D Officer 63 2022-06-27
Director TitleAgeSince
Director/Board Member 63 2007-05-31
Director/Board Member 65 2025-06-24
Director/Board Member 50 2020-05-31
Change 5-day change 1-year change 3-year change Capi.($)
-1.81%-.--% - - 2.64B
+0.96%-2.28%-22.54%+1.81% 177B
+0.43%+2.33%-0.17%+13.56% 120B
-0.67%-0.76%+10.64%+79.22% 61.69B
-0.38%+3.20%-0.35%-29.86% 50.64B
+0.27%-3.53%+3.35%+39.11% 48.16B
+1.99%+4.72%+14.75%-7.82% 32.62B
+2.52%-3.73% - - 28.17B
-0.48%+7.40%+40.07%-8.30% 25.69B
+0.07%-1.06%-10.97%+3.77% 21.33B
Average +0.28%-1.21%+4.35%+11.44% 62.75B
Weighted average by Cap. +0.53%-1.25%-3.59%+12.70%

Financials

2027 *2028 *
Net sales 3,189B 20.56B 17.81B 16.84B 15.24B 28.61B 1,972B 28.82B 201B 77.3B 1T 77.21B 75.5B 3,280B 21.14B 18.31B 17.32B 15.68B 29.42B 2,028B 29.65B 207B 79.51B 1,028B 79.42B 77.66B
Net income 23.49B 151M 131M 124M 112M 211M 14.52B 212M 1.48B 569M 7.36B 569M 556M 27.35B 176M 153M 144M 131M 245M 16.91B 247M 1.72B 663M 8.58B 662M 648M
Net Debt - -
Logo Alfresa Holdings Corporation
Alfresa Holdings Corporation is a Japan-based holding company primarily engaged in the wholesale of drugs. The Company operates in four business segments. The Pharmaceutical Wholesale segment is engaged in the wholesale of medical products, test reagents, as well as medical equipment and materials. The Self Medication Wholesale segment is engaged in the wholesale of general drugs. The Pharmaceutical Manufacture segment is engaged in the manufacture and sale of pharmaceuticals, test reagents, medical equipment and implements, as well as pharmaceutical powders. The Medical-Related segment is mainly engaged in operation of pharmacies. The others business is engaged in the information system business, the transportation business, the warehousing business, the insurance agency business, the real estate management business, the sale of miscellaneous goods, as well as the manpower dispatching business, among others.
Employees
12,525
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
2
Last Close Price
2,336.50JPY
Average target price
2,340.00JPY
Spread / Average Target
+0.15%

Quarterly revenue - Rate of surprise

LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!